Evaluation of the Early Results of Percutaneous Ethanol Ablation in Patients with Primary Hyperparathyroidism
Percutaneous ethanol ablation (PEA) is an alternative non-surgical method for the treatment of patients with primary hyperparathyroidism (PHPT), suitable in cases with comorbidities and high surgical risk.
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-04-01
|
Series: | Acta Medica Bulgarica |
Subjects: | |
Online Access: | https://doi.org/10.2478/amb-2022-0001 |